Tyligand Pharmaceuticals (suzhou) Limited
Clinical trials sponsored by Tyligand Pharmaceuticals (suzhou) Limited, explained in plain language.
Upcoming readouts
Trials from this sponsor expected to report results within the next 12 months.
- New pill targets Hard-to-Treat cancer mutation in early trial Results expected Oct 2026 (estimated)